for its Abbreviated New Drug Application for Canagliflozin and Metformin Hydrochloride Extended-Release Tablets, 50 mg/500 mg, 50 mg/1,000 mg, 150 mg/500 mg, and 150 mg/1,000 mg to market a generic ...

Dr. Reddy’s Saxagliptin and Metformin Hydrochloride Extended-Release Tablets are supplied in a strength of 2.5 mg/1000 mg in bottle count of 60 and strengths of 5 mg/500 mg and 5 mg/1000 mg each ...

Can we get metformin er 500 cost with paypal Deficiency Area Phase 1, Chandigarh No. Tibba, Medicinal Point, Ludhiana - Dist. Chandan Nagar, Mumbai Near No. Makarba, Haridwar Except No. Kandivali West ...

Marksans Pharma has issued voluntary recall of one batch of Metformin Extended Release Tablets USP 500 mg (11279 bottles, Lot No. XP9004) due to detection of NOMA as a matter of abundant precaution.

A former senior analyst at U.S. trading company Freepoint Commodities has sued the company, alleging that top executives pressured employees to facilitate insider trading and retaliated against ...

The Therapeutic Goods Administration (TGA) has been notified of current shortages for multiple brands of metformin extended-release (XR) 500 mg tablets. The shortages are expected to continue until 5 ...

are strengthening their association with the launch of Metformin Oral Solution in the US market ... and manufacturing of generic and branded products in liquid and semi-solid dosage forms. The Company ...

Apotex Inc. is recalling eight lots of its 500 mg extended release metformin tablets ("APO-Metformin ER") because they contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA ...

Product: Certain lots of APO-Metformin ER (extended release) 500 mg tablets manufactured by Apotex Inc. Issue: Apotex Inc. is recalling certain lots because they contain a nitrosamine impurity above ...

Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration (USFDA) for Metformin Hydrochloride Extended‐Release Tablets USP, 500 mg and 1000 mg, the ...

--(BUSINESS WIRE)--Santarus, Inc. (NASDAQ: SNTS) and Depomed, Inc. (NASDAQ: DEPO) today announced that supply of GLUMETZA ® 500 mg (metformin HCl extended release tablets) to wholesalers and ...